# Re-evaluation of the Effect Site Model of the PKPD Propofol Eleveld Model

> **NCT06417645** · PHASE4 · RECRUITING · sponsor: **Universidad del Desarrollo** · enrollment: 24 (estimated)

## Conditions studied

- Healthy
- Surgery

## Interventions

- **DRUG:** fixed propofol infusion 15 mg/kg/h until 1% BSR (burst suppression ratio)

## Key facts

- **NCT ID:** NCT06417645
- **Lead sponsor:** Universidad del Desarrollo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2013-09-01
- **Primary completion:** 2023-09-15
- **Final completion:** 2024-09-15
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06417645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06417645, "Re-evaluation of the Effect Site Model of the PKPD Propofol Eleveld Model". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06417645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*